Advancedmetabolism
DNA Repair Mechanisms: Fixing the Genome
Overview
DNA suffers thousands of damaging events per cell per day — yet mutations remain rare, thanks to an elaborate repair toolkit. This guide surveys each system: polymerase proofreading during synthesis, mismatch repair that catches what proofreading missed, base excision repair for small lesions, nucleotide excision repair for bulky helix distortions (whose failure causes xeroderma pigmentosum), and the two strategies for double-strand breaks — accurate homologous recombination versus quick-but-sloppy non-homologous end joining. You will see how repair defects cause cancer predisposition.
Learning objectives
- Name the major repair pathways and the lesion each handles.
- Explain mismatch repair and how it identifies the new strand.
- Contrast base excision vs nucleotide excision repair.
- Compare homologous recombination and non-homologous end joining for double-strand breaks.
Structure and function
| Part | Structure | Function |
|---|---|---|
| Proofreading (3'→5' exonuclease) | Polymerase's built-in error removal during synthesis. | First line of defense: excises mismatched nucleotides immediately after insertion. |
| Mismatch repair (MMR) | Post-replication system (MutS/MutL homologs) scanning for mispaired bases. | Catches errors proofreading missed; defects cause Lynch syndrome (hereditary colon cancer). |
| Base excision repair (BER) | Removes single damaged bases: glycosylase cuts the base, AP endonuclease cuts the backbone, polymerase fills. | Handles small, non-distorting lesions — oxidized, alkylated, or deaminated bases. |
| Nucleotide excision repair (NER) | Excises a ~30-nucleotide patch around bulky, helix-distorting damage. | Fixes thymine dimers and chemical adducts; failure causes xeroderma pigmentosum (extreme sun sensitivity). |
| Homologous recombination (HR) | Double-strand break repair using the sister chromatid as an accurate template. | Error-free but restricted to S/G2 when a sister copy exists; BRCA1/BRCA2 participate here. |
| Non-homologous end joining (NHEJ) | Directly ligates broken ends with minimal processing, active throughout the cycle. | Fast but error-prone: often inserts/deletes bases at the join — the cell's emergency patch. |
Diagram: a DNA helix with five damage/repair stations. 1) Proofreading: polymerase with a U-turn arrow excising a mismatched base. 2) MMR: MutS clamp on a mismatch, new strand nicked and excised, resynthesized. 3) BER: a damaged base flipped out by glycosylase, backbone nicked, single nucleotide replaced. 4) NER: a thymine dimer bulge with a ~30-nt patch being cut out on both sides and refilled. 5) DSB: a broken helix with two paths — HR (sister chromatid template, accurate) vs NHEJ (ends glued, small indel scar). A disease panel links XP→NER, Lynch→MMR, BRCA cancers→HR.
The scale of the problem
Each human cell endures tens of thousands of DNA lesions daily: spontaneous depurination, oxidative hits from metabolism's own free radicals, replication errors, plus environmental UV and chemicals. Without repair, genomes would disintegrate within days. The cell's answer is layered defense — multiple specialized systems, each handling the lesions it recognizes best, arranged so that what one misses, the next catches. Understanding repair means understanding why mutation rates stay low despite constant assault.
Proofreading (during synthesis) → mismatch repair (after synthesis) → excision repair (lesions) → break repair (DSBs) → apoptosis (if overwhelmed). Each layer catches what the previous missed; p53 triggers the last resort.
Proofreading and mismatch repair: catching replication errors
DNA polymerase proofreads in real time with its 3'→5' exonuclease, removing mismatches as they're added. What escapes is caught by mismatch repair: MutS homologs clamp onto the distortion of a mispaired base, MutL homologs coordinate excision of the new strand's segment (identified in eukaryotes by nicks and PCNA orientation marking the fresh strand), and polymerase resynthesizes it correctly. MMR defects cause Lynch syndrome — hereditary non-polyposis colon cancer — because uncorrected replication errors accumulate into microsatellite instability.
The system must fix the new strand, not the template. In bacteria, transient under-methylation marks new DNA; in eukaryotes, pre-existing nicks (like Okazaki fragment junctions) and PCNA orientation identify the fresh strand — an elegant solution to a tricky problem.
Excision repair: BER for small lesions, NER for bulky ones
Base excision repair handles subtle damage: a DNA glycosylase flips out the damaged base (oxidized, alkylated, deaminated, or uracil misincorporated) and removes it, AP endonuclease nicks the backbone, polymerase inserts the correct nucleotide, ligase seals. Nucleotide excision repair handles helix-distorting bulky lesions — thymine dimers, chemical adducts: the damage is recognized, dual incisions cut out a ~24-32 nucleotide patch containing it, and the gap is refilled using the intact strand. NER's failure causes xeroderma pigmentosum: patients cannot repair UV damage and develop skin cancers in childhood from ordinary sunlight.
BER: single damaged BASE removed (glycosylase), small lesion, no distortion. NER: patch of NUCLEOTIDES removed (~30), bulky distorting lesion. Name says it: base vs nucleotide excision.
Double-strand breaks: the emergency hierarchy
Double-strand breaks (from radiation, replication fork collapse) are the most dangerous lesion — no intact strand remains as template. The cell chooses by cell-cycle phase: homologous recombination (HR) uses the sister chromatid as a perfect template for error-free repair, but requires S/G2; non-homologous end joining (NHEJ) simply trims and ligates the ends — fast, available always, but mutagenic (small insertions/deletions at the join). BRCA1/BRCA2 promote HR; their mutation forces reliance on sloppy NHEJ, driving the genome instability behind hereditary breast/ovarian cancers.
Gene-editing's knockout strategy relies on this: Cas9 makes a double-strand break, and the cell's own error-prone NHEJ introduces the disrupting indel. The therapy hijacks the repair system's sloppiness.
When repair fails: disease and the last resort
Every repair defect has a signature disease: XP (NER) → UV-driven skin cancers; Lynch syndrome (MMR) → colon/endometrial cancers; BRCA mutations (HR) → breast/ovarian cancers; ataxia-telangiectasia (break signaling) → radiation sensitivity. When damage overwhelms all repair, p53 triggers apoptosis — the final quality control, deleting the cell rather than risking a mutated genome. Cancer is, in this view, what happens when both repair and the apoptotic backup fail in the same lineage.
Some lesions can't be repaired before replication — translesion polymerases then copy past them inaccurately (damage tolerance, not repair). It's a deliberate trade: a mutation now beats a collapsed fork and cell death.
Key points
- DNA faces tens of thousands of lesions daily; layered repair keeps mutations rare.
- Proofreading (real-time) + mismatch repair (MutS/MutL, post-replication) handle replication errors; MMR defects cause Lynch syndrome.
- BER removes single damaged bases (glycosylase); NER excises ~30-nt patches around bulky lesions (thymine dimers); NER failure = xeroderma pigmentosum.
- Double-strand breaks: homologous recombination (accurate, needs sister chromatid; BRCA-dependent) vs NHEJ (fast, mutagenic).
- Overwhelming damage triggers p53-mediated apoptosis — repair's last-resort backup.
Common misconceptions
✓ Truth: Repair is excellent but imperfect — it reduces errors to ~1 per billion bases, not zero. The residual failures are mutations, and their slow accumulation drives both evolution and (when hitting growth genes) cancer.
✓ Truth: Each pathway is specialized: proofreading exonuclease, MMR's strand-directed excision, BER's base flipping, NER's patch excision, HR's templated repair, NHEJ's direct ligation. Different lesions, different machineries — no universal fix exists.
✓ Truth: Only homologous recombination is accurate, and it's limited to S/G2. The default NHEJ pathway is deliberately sloppy — trading accuracy for speed, since an unrepaired break is worse than a small mutation.
Practice questions
Q1. Xeroderma pigmentosum results from defective:
- Mismatch repair
- Nucleotide excision repair
- Base excision repair
- Proofreading exonuclease
XP patients cannot perform NER, so UV-induced thymine dimers go unrepaired, causing extreme sun sensitivity and childhood skin cancers. MMR defects cause Lynch syndrome; BER handles small base lesions.
Q2. Homologous recombination differs from non-homologous end joining in that HR:
- Is faster and works in all cell-cycle phases
- Uses the sister chromatid as a template for error-free repair
- Directly ligates broken ends
- Requires no template
HR copies the intact sister chromatid to accurately restore the broken sequence — error-free but limited to S/G2. NHEJ directly ligates ends quickly but introduces indels; it needs no template and works throughout the cycle.
Q3. In base excision repair, the damaged base is first removed by:
- DNA glycosylase flipping the base out
- Helicase unwinding the helix
- Ligase sealing the backbone
- Primase synthesizing RNA
A DNA glycosylase recognizes the damaged base, flips it out of the helix, and cleaves it from the sugar — then AP endonuclease nicks the backbone for polymerase refill and ligase sealing. Helicase, ligase, and primase serve other roles.
Click a question to reveal the answer and explanation.
Frequently asked questions
How does mismatch repair avoid 'fixing' the correct template strand by mistake?
It must distinguish new from old: bacteria use transient under-methylation of the new strand; eukaryotes use pre-existing nicks (e.g., Okazaki fragment junctions) and PCNA orientation to identify the freshly synthesized strand. Only the new strand is excised and resynthesized — correcting the copy, preserving the original.
Why do BRCA1/BRCA2 mutations specifically raise breast and ovarian cancer risk?
These proteins promote homologous recombination, the accurate double-strand break repair. Without them, cells rely on error-prone NHEJ, accumulating mutations and chromosome rearrangements. Breast and ovarian tissues are especially vulnerable due to hormonal proliferation plus estrogen-related DNA damage — though the genes act in all cells.
What's the difference between repairing a thymine dimer and repairing an oxidized base?
Scale of the fix: a thymine dimer distorts the helix, requiring nucleotide excision repair to cut out a ~30-nucleotide patch. An oxidized base doesn't distort much, so base excision repair just flips out and replaces that single base. Bulky/distorting → NER patch; small/non-distorting → BER single base.
If NHEJ is mutagenic, why does the cell use it at all?
Because a persistent double-strand break is worse than a small mutation — broken chromosomes cause cell death or catastrophic rearrangements. NHEJ's speed (active throughout the cell cycle, no template needed) makes it the emergency first responder; accuracy is sacrificed for survival.